TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PE Bioprocess Consulting AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
359
|
287
|
216 |
| Financial expenses |
116
|
0
|
14 |
| Earnings before taxes |
-89
|
12
|
210 |
| EBITDA |
23
|
4
|
-46 |
| Total assets |
510
|
603
|
656 |
| Current assets |
381
|
361
|
430 |
| Current liabilities |
96
|
58
|
64 |
| Equity capital |
415
|
545
|
592 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.4%
|
90.4%
|
90.2% |
| Turnover per employee |
359
|
287
|
216 |
| Profit as a percentage of turnover |
-24.8%
|
4.2%
|
97.2% |
| Return on assets (ROA) |
5.3%
|
2.0%
|
34.1% |
| Current ratio |
396.9%
|
622.4%
|
671.9% |
| Return on equity (ROE) |
-21.4%
|
2.2%
|
35.5% |
| Change turnover |
67
|
56
|
-168 |
| Change turnover % |
23%
|
24%
|
-44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.